Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

New RORC modulators divulged by Bristol-Myers Squibb

June 7, 2018

Jiangsu Chia Tai Tianqing Pharmaceutical Group, Medshine Discovery identify HBV cccDNA inhibitors

June 7, 2018

Shandong Luoxin Pharmacy Group, Luoxin Biotechnology Shanghai Co. patent BRD4/1/2 inhibitors

June 7, 2018

Merck & Co. describes DGAT-2 inhibitors

June 6, 2018

Amgen identifies new apelin receptor agonists

June 6, 2018

EZH2 inhibitors patented by Yangtze River Pharmaceutical, Shanghai Haiyan Pharmaceutical Technology

June 6, 2018

Navitor Pharmaceuticals divulges mTOR complex 1 and glucose transport inhibitors

June 6, 2018

Korea Research Institute of Chemical Technology identifies DAPK2 inhibitors

June 6, 2018

PFK/FBPase 1 inhibitors identified at Merck KGaA

June 5, 2018

Dynavax Technologies presents Toll-like receptor 7/8/9 antagonists

June 5, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...